Abstract
Protein aggregation is facilitated by the generation of partially folded intermediates that lack most of the tertiary interactions, but retain the complete secondary structure. These partially folded states cross-link each other to form protein aggregates. Protein aggregates in an advanced stage result in the formation of amyloid fibrils, which have high tensile strength. These amyloid fibrils are associated with a number of pathologies, especially Alzheimer’s disease, which involves the aggregation of the Aβ peptide. In recent years, much attention has been paid to the generation of potent therapeutics to reduce Aβ peptide fibrillation. This review summarizes the range of molecules used for this therapy, showing their potency against Aβ amyloids, and suggests a positive future for the eradication of this dreaded disease.
Keywords: Aβ peptide, Alzheimer’s disease, amyloid fibrils, protein aggregates, nanotechnological approach.
Current Drug Metabolism
Title:Therapeutic Interventions for the Suppression of Alzheimer’s Disease: Quest for a Remedy
Volume: 16 Issue: 5
Author(s): Naveed Ahmad Fazili, Aabgeena Naeem, Ghulam Md. Ashraf, Siew Hua Gan and Mohammad A. Kamal
Affiliation:
Keywords: Aβ peptide, Alzheimer’s disease, amyloid fibrils, protein aggregates, nanotechnological approach.
Abstract: Protein aggregation is facilitated by the generation of partially folded intermediates that lack most of the tertiary interactions, but retain the complete secondary structure. These partially folded states cross-link each other to form protein aggregates. Protein aggregates in an advanced stage result in the formation of amyloid fibrils, which have high tensile strength. These amyloid fibrils are associated with a number of pathologies, especially Alzheimer’s disease, which involves the aggregation of the Aβ peptide. In recent years, much attention has been paid to the generation of potent therapeutics to reduce Aβ peptide fibrillation. This review summarizes the range of molecules used for this therapy, showing their potency against Aβ amyloids, and suggests a positive future for the eradication of this dreaded disease.
Export Options
About this article
Cite this article as:
Ahmad Fazili Naveed, Naeem Aabgeena, Md. Ashraf Ghulam, Hua Gan Siew and A. Kamal Mohammad, Therapeutic Interventions for the Suppression of Alzheimer’s Disease: Quest for a Remedy, Current Drug Metabolism 2015; 16 (5) . https://dx.doi.org/10.2174/1389200215999141125115749
DOI https://dx.doi.org/10.2174/1389200215999141125115749 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Tissue Distribution and Metabolism of Micro- and Nanoparticles and Medical Implants
With the continuous advancement of modern science and engineering, numerous functional materials and active molecules have been developed and utilized in various industrial, medical, and food applications. Many of these can enter the body, either actively or passively, and have significant and intricate impacts on human health. For example, biomaterials ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Disaggregation of Tau as a Therapeutic Approach to Tauopathies
Current Alzheimer Research Compensating, Controlling, Resigning and Accepting-Older Persons Perception of Physical Decline
Current Aging Science Review of Synthesis, Assay, and Prediction of β and γ-secretase Inhibitors
Current Topics in Medicinal Chemistry CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Attention Deficit Hyperactive Disorder and Occurrence of Tic Disorders in Children and Adolescents—What is the Verdict
Current Pediatric Reviews Spectroscopic and Chromatographic Characterization of Crude Natural Shilajit from Himachal Pradesh, India
The Natural Products Journal On the Role of Rab5 in Cell Migration
Current Molecular Medicine Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia
CNS & Neurological Disorders - Drug Targets Microemulsions and Nanoemulsions for Targeted Drug Delivery to the Brain
Current Nanoscience 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening
Medicinal Chemistry Breaking the Chain of Abuse: A Therapeutic Approach for Adolescent Mothers and Their Children
Adolescent Psychiatry Matching Intervention to Need in Juvenile Justice: The CASII Level of Care Determination
Adolescent Psychiatry Adverse Drug Reactions: Trends in a Tertiary Care Hospital
Current Drug Safety Melatonin Therapy of Pediatric Sleep Disorders: Recent Advances, Why it Works, Who are the Candidates and How to Treat
Current Pediatric Reviews Editorial [Hot Topic: Monotherapy to Polytherapy: Antiepileptic Drug Conversions Through the Spectrum of Epilepsy Care (Guest Editor: Erik K. St. Louis)]
Current Neuropharmacology Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine
Mini-Reviews in Medicinal Chemistry Pre-Clinical Evidence that Corticotropin-Releasing Factor (CRF) Receptor Antagonists are Promising Targets for Pharmacological Treatment of Alcoholism
CNS & Neurological Disorders - Drug Targets Pharmacological and Biological Activities of Xanthones
Anti-Infective Agents in Medicinal Chemistry Development of Poly(lactide-co-glicolide) Nanoparticles Incorporating Morphine Hydrochloride to Prolong its Circulation in Blood
Current Pharmaceutical Design